BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21094895)

  • 1. Evolution of genes for incretin hormones and their receptors.
    Irwin DM
    Vitam Horm; 2010; 84():1-20. PubMed ID: 21094895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incretin hormones and the expanding families of glucagon-like sequences and their receptors.
    Irwin DM; Prentice KJ
    Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():69-81. PubMed ID: 21824259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of new hormone function: loss and gain of a receptor.
    Irwin DM; Wong K
    J Hered; 2005; 96(3):205-11. PubMed ID: 15653559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular evolution of mammalian incretin hormone genes.
    Irwin DM
    Regul Pept; 2009 Jun; 155(1-3):121-30. PubMed ID: 19374921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incretin hormones GIP and GLP-1 in diabetic rats: effects on insulin secretion and small bowel motility.
    Edholm T; Cejvan K; Abdel-Halim SM; Efendic S; Schmidt PT; Hellström PM
    Neurogastroenterol Motil; 2009 Mar; 21(3):313-21. PubMed ID: 19126188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biology of incretin hormones.
    Drucker DJ
    Cell Metab; 2006 Mar; 3(3):153-65. PubMed ID: 16517403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incretin and islet hormonal responses to fat and protein ingestion in healthy men.
    Carr RD; Larsen MO; Winzell MS; Jelic K; Lindgren O; Deacon CF; Ahrén B
    Am J Physiol Endocrinol Metab; 2008 Oct; 295(4):E779-84. PubMed ID: 18612044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociated effects of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide-1 on beta-cell secretion and insulin clearance in mice.
    Pacini G; Thomaseth K; Ahrén B
    Metabolism; 2010 Jul; 59(7):988-92. PubMed ID: 20153002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of metoclopramide on duodenal motility and flow events, glucose absorption, and incretin hormone release in response to intraduodenal glucose infusion.
    Kuo P; Bellon M; Wishart J; Smout AJ; Holloway RH; Fraser RJ; Horowitz M; Jones KL; Rayner CK
    Am J Physiol Gastrointest Liver Physiol; 2010 Dec; 299(6):G1326-33. PubMed ID: 20829521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GIP: no longer the neglected incretin twin?
    Kulkarni RN
    Sci Transl Med; 2010 Sep; 2(49):49ps47. PubMed ID: 20844284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.
    Theodorakis MJ; Carlson O; Michopoulos S; Doyle ME; Juhaszova M; Petraki K; Egan JM
    Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E550-9. PubMed ID: 16219666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
    Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
    Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small intestinal glucose exposure determines the magnitude of the incretin effect in health and type 2 diabetes.
    Marathe CS; Rayner CK; Bound M; Checklin H; Standfield S; Wishart J; Lange K; Jones KL; Horowitz M
    Diabetes; 2014 Aug; 63(8):2668-75. PubMed ID: 24696447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the cellular and biological properties of DPP-IV-resistant N-glucitol analogues of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide.
    Green BD; Gault VA; O'Harte FP; Flatt PR
    Diabetes Obes Metab; 2005 Sep; 7(5):595-604. PubMed ID: 16050953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of the incretin hormones: glucagon-like peptide-1 and glucose-dependent insulinotropic peptide.
    Kuhre RE; Wewer Albrechtsen NJ; Hartmann B; Deacon CF; Holst JJ
    J Diabetes Complications; 2015 Apr; 29(3):445-50. PubMed ID: 25623632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analogs of glucagon-like peptide-1 (GLP-1): an old concept as a new treatment of patients with diabetes mellitus type 2].
    Diamant M; Bunck MC; Heine RJ
    Ned Tijdschr Geneeskd; 2004 Sep; 148(39):1912-7. PubMed ID: 15495988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia.
    Toft-Nielsen M; Madsbad S; Holst JJ
    Diabetologia; 1998 Oct; 41(10):1180-6. PubMed ID: 9794105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathophysiologic role of incretins.
    Freeman JS
    J Am Osteopath Assoc; 2007 May; 107 Suppl():S6-9. PubMed ID: 17724014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of incretin on diabetes mellitus.
    Sanusi H
    Acta Med Indones; 2009 Oct; 41(4):205-12. PubMed ID: 20737753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.
    Nauck MA; El-Ouaghlidi A; Gabrys B; Hücking K; Holst JJ; Deacon CF; Gallwitz B; Schmidt WE; Meier JJ
    Regul Pept; 2004 Nov; 122(3):209-17. PubMed ID: 15491793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.